A lifestyle intervention was associated with significant reductions in BMI, urine albumin-to-creatinine ratio and eGFR for ...

The use of SGLT2 inhibitors, especially dapagliflozin, can lower adiposopathy parameters in patients with CKD, regardless of diabetes status, a cohort study finds.

Chronic kidney disease significantly impacts cardiovascular health, highlighting the need for effective screening and ...

Combination therapy with a nonsteroidal mineralocorticoid receptor antagonist and an SGLT2 inhibitor reduced albuminuria more ...

Systemic inflammatory cytokine profiling can predict the risk for kidney failure and long-term mortality in patients with ...

The Kidney Disease Symptom Score (KDSS) has temporal stability for patients with non-dialysis-dependent chronic kidney ...

With kidney disease on the rise worldwide, we asked the nation's top specialists to share the early signs of the condition. Keep reading for the surprising kidney disease symptoms to watch out for and ...

CKD complicates cancer treatment, reducing adjuvant chemotherapy use and increasing mortality risk, necessitating ...

At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight, with ...

A single-arm intervention study in Japanese adults with moderate chronic kidney disease found that replacing breakfast with ...

Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical ...

Office and ambulatory BP improved, with minimal side effects, although some say edema needs to be watched carefully.